Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > December 2007

« Previous month Next month »

New company formed for drug delivery tech

21-Dec-2007 - Jerusalem-based Yissum has formed a spin-off company Nanolymf, which will be dedicated to advancing a nanotechnology controlled-release drug delivery platform.

Pharmaceutical manufacturing: news in brief

21-Dec-2007 - brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

FMC expands excipient production

21-Dec-2007 - FMC BioPolymer is to expand its microcrystalline cellulose (MCC) production in a bid to meet demand for the company's excipients.

Consort Medical feeling the loss of Exubera

20-Dec-2007 - Consort Medical's UK operations may be in line for more job losses as further collateral damage from Pfizer's withdrawal of Exubera from the market.

Enzo to expand in Europe with Belgian distributor buy-out

20-Dec-2007 - Enzo Life Sciences has signed a letter of intent to acquire Belgian life science tools distributor 10P's BVBA for an undisclosed amount.

Product news in brief - week 51

20-Dec-2007 - brings you a round up of the latest product news and releases from Agilent, Caliper, Grabner, Micronic, Millipore, Torrey Pines and Warner.

Biochips help reduce the need for animal testing

20-Dec-2007 - US researchers have developed a new biochip technology that could dramatically reduce the need for animal testing during drug development safety studies.

Flamel tech used for Merck Serono drug

20-Dec-2007 - France-based Flamel Technologies and Merck Serono have shook hands on a new €2m ($2.9m) deal which would see Flamel's Medusa technology used to develop an extended-release profile of an undisclosed...

Keata buys Pfizer's Canadian facility

20-Dec-2007 - PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's manufacturing facility in Arnprior, Canada, which the drug giant has been trying to pass on for over a year.

Two dimensions are better than one when profiling metabolites

20-Dec-2007 - US researchers have shown that 2D NMR (nuclear magnetic resonance) experiments can greatly enhance the ability of metabolic profiling to quantify disease identification and progression.

New drug on the blocks for athletes

19-Dec-2007 - Scientists have discovered a potential new drug target that will prick up the ears of sportsmen and athletes alike. Not that this is an performance-enhancing drug; instead, it could help...

Affymetrix buys USB to accelerate genetic tools development

19-Dec-2007 - Microarray expert Affymetrix is to buy molecular biology reagent firm USB Corporation for $75m (€52m) in a bid to accelerate the development of new genetic analysis tools.

Industry news in brief - week 51

19-Dec-2007 - brings you a round up of recent industry news, with developments at Agilent, Bruker BioSpin, EMD Chemicals, Gene Logic, Paraytec and Thermo Fisher Scientific.

Mapping the 'human embryome' in BioTime

19-Dec-2007 - BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem...

William Ransom & Son's future profitability questionable

19-Dec-2007 - UK-based William Ransom & Son has a shaky future ahead following a disappointing and unacceptable six-month financial report, compounded by a suspension of the companys manufacturing license.

Biopartners ends supply agreement with TMH

19-Dec-2007 - Biopartners has terminated its supply agreement with The Medical House because of a go-slow in receiving functional drug delivery devices.

Eli Lilly, Shire, Pregis, and Eisai - People on the move

19-Dec-2007 - Eli Lilly, Shire, Pregis, and Eisai have all had people on the move in the world of pharmaceutical manufacturing.

Affymetrix simplifies genetic copy number analysis

18-Dec-2007 - Affymetrix has launched a new analysis tool for determining genetic variations in whole-genome association and cytogenetic studies that is up to 10 times more sensitive than competing platforms.

Siegfried and Arena sign contract manufacturing deal

18-Dec-2007 - Siegfried has signed a $27.7m contract with Arena Pharmaceuticals to manufacture Arena's Phase III oral obesity drug candidate lorcaserin hydrochloride.

Chao Centre gets rights to manufacture TB drug

18-Dec-2007 - Eli Lilly has handed over the manufacturing reins of the antibiotic Seromycin to the Chao Centre for Industrial Pharmacy and Contract Manufacturing.

Harvard Bioscience knocks back Skystone takeover bid

18-Dec-2007 - Harvard Bioscience has rejected an unsolicited acquisition offer from Skystone Advisors to acquire all outstanding shares of common stock in the life science tools and instrument manufacturer.

Excipient market set to change, says report

18-Dec-2007 - Advances in the pharmaceutical industry are expected to have an impact on pharmaceutical excipients within the next decade, a new report claims.

Pronova and FMC to develop seaweed-derived capsules

17-Dec-2007 - Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology.

Patheon reveals plans to tackle Puerto Rico problems

17-Dec-2007 - Patheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability.

Japan says Tamiflu/psychiatric link unclear

17-Dec-2007 - Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...